Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to ...

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that ...

Pfizer Inc PFE, BioNTech SE BNTX, and Moderna Inc MRNA were named in lawsuits by Promosome accusing their COVID-19 vaccines of infringing a patent related to messenger RNA (mRNA) technology. The ...

Three of the biggest COVID-19 vaccine developers are heading into a legal battle. Moderna Inc. said it has filed lawsuits alleging the Pfizer Inc.-Biontech SE Comirnaty vaccine infringes patents ...

The Cambridge biotech said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in an ongoing dispute with Pfizer and BioNTech over rival COVID-19 ...

Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc PFE and BioNTech SE BNTX, of patent infringement related to messenger RNA ...

CureVac (CVAC) announced Friday that its motion to transfer the ongoing patent litigation filed by Pfizer (PFE)/BioNTech (BNTX) has been granted. Rad more here.

Pfizer Inc and its German partner, BioNTech SE , fired back at Moderna Inc on Monday in a patent lawsuit over their rival COVID-19 vaccines, seeking dismissal of the lawsuit in Boston federal ...

COVID-19 vaccine partners Pfizer and BioNTech are countersuing Cambridge-based Moderna in an ongoing fight over the technology used in the shots.

Moderna sued Pfizer and its German partner BioNTech on Friday, alleging the rival firms improperly used its foundational technology in developing their coronavirus vaccine.

Rival Covid-19 jab developers face off in High Court patent trial Moderna, Pfizer and BioNTech are in a dispute over the rights to life-saving vaccine technology patents.